Global Alliance for iPSC Therapies
The Global Alliance for iPSC Therapies (GAiT) is an international resource to
facilitate the therapeutic use of HLA homozygous clinical-grade induced
pluripotent stem cell lines for the benefit of patients globally. GAiT is
supported by an international consortium of organisations including the Cell
and Gene Therapy Catapult (London, UK), the Centre for Commercialisation of
Regenerative Medicine (Toronto, Canada), the Korea HLA-Typed iPSC Banking
Initiative (Seoul, Korea) and the New York Stem Cell Foundation (New York,
USA).
GAiT’s mission:
To enable the global human community the opportunity to benefit from the new
generation of cell therapies by facilitating the development of, and access
to, clinical-grade and haplotyped induced pluripotent stem cells for the
manufacture of cell therapy products.”
GAiT’s vision:
That patients globally will have equity of access to this new generation of
iPSC-derived cell therapy products.
People involved in the collaboration with hPSCreg:
Stephen Sullivan PhD MBA FRSM